1990 to 2021 Saw Increase in Global Burden of Diabetic Nephropathy

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, March 17, 2025 -- The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, according to a study published online Feb. 21 in Frontiers in Endocrinology.

Xiao Ma, from The Third People's Hospital of Chengdu in China, and colleagues used data from 1990 to 2021 to analyze the trends and future projections of the worldwide burden of chronic kidney disease (CKD) caused by type 1 and type 2 diabetes mellitus based on the Global Burden of Disease Study. Trends in the burden of each disease subtype and different regions were calculated using Estimated Annual Percentage Changes (EAPCs).

The researchers found that the burden of diabetic nephropathy and its EAPCs varied significantly across different sociodemographic index subgroups of countries and regions worldwide. There was also significant variability seen in the influence of different age groups and metabolic factors on the burden of diabetic nephropathy. There was a positive correlation observed for the effects of metabolic factors on the number of deaths and mortality with age. Different metabolic factors have different effects on the mortality of CKD due to type 1 diabetes and CKD due to type 2 diabetes. The global burden of diabetic nephropathy is predicted to continue increasing in the absence of interventions from 2022 t0 2050 based on the ARIMA (Autoregressive Integrated Moving Average) model.

"In the absence of interventions, the global burden of diabetic nephropathy is projected to continue to rise annually from 2022 to 2050, placing even greater stress on the global health system in the future," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-18 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords